Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Derosa

Showing results (11-20 of 250) with videos related to

Pageof 25
Sort By:
Current Molecular Pharmacology|November 30, 2011
Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular riskGiuseppe Derosa, Pamela Maffioli
Nature Reviews. Endocrinology|July 30, 2014
Diabetes: safety and efficacy of albiglutide-results from two trialsGiuseppe Derosa, Pamela Maffioli
Clinical Therapeutics|May 8, 2012
Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic reviewGiuseppe Derosa, Pamela Maffioli
Expert Review of Cardiovascular Therapy|June 12, 2013
Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressureGiuseppe Derosa, Pamela Maffioli
Current Topics in Medicinal Chemistry|December 24, 2013
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate teaGiuseppe Derosa, Pamela Maffioli
Archives of Medical Science : AMS|November 28, 2012
α-Glucosidase inhibitors and their use in clinical practiceGiuseppe Derosa, Pamela Maffioli
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 28, 2011
Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetesGiuseppe Derosa, Pamela Maffioli
Expert Review of Cardiovascular Therapy|November 23, 2011
Nifedipine and telmisartan for the treatment of hypertension: the TALENT studyGiuseppe Derosa, Pamela Maffioli
Expert Review of Endocrinology & Metabolism|October 10, 2018
Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practiceGiuseppe Derosa, Pamela Maffioli
Therapeutics and Clinical Risk Management|September 22, 2018
Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetesGiuseppe Derosa, Pamela Maffioli
Pageof 25

Showing results (11-20 of 250) with videos related to

Sort By:
Pageof 25
Current Molecular Pharmacology|November 30, 2011
Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists on glycemic control, lipid profile and cardiovascular riskGiuseppe Derosa, Pamela Maffioli
Nature Reviews. Endocrinology|July 30, 2014
Diabetes: safety and efficacy of albiglutide-results from two trialsGiuseppe Derosa, Pamela Maffioli
Clinical Therapeutics|May 8, 2012
Efficacy and safety profile evaluation of acarbose alone and in association with other antidiabetic drugs: a systematic reviewGiuseppe Derosa, Pamela Maffioli
Expert Review of Cardiovascular Therapy|June 12, 2013
Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressureGiuseppe Derosa, Pamela Maffioli
Current Topics in Medicinal Chemistry|December 24, 2013
Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate teaGiuseppe Derosa, Pamela Maffioli
Archives of Medical Science : AMS|November 28, 2012
α-Glucosidase inhibitors and their use in clinical practiceGiuseppe Derosa, Pamela Maffioli
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|July 28, 2011
Patient considerations and clinical utility of a fixed dose combination of saxagliptin/metformin in the treatment of type 2 diabetesGiuseppe Derosa, Pamela Maffioli
Expert Review of Cardiovascular Therapy|November 23, 2011
Nifedipine and telmisartan for the treatment of hypertension: the TALENT studyGiuseppe Derosa, Pamela Maffioli
Expert Review of Endocrinology & Metabolism|October 10, 2018
Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practiceGiuseppe Derosa, Pamela Maffioli
Therapeutics and Clinical Risk Management|September 22, 2018
Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetesGiuseppe Derosa, Pamela Maffioli
Pageof 25